These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Macrophage-derived prostaglandin E modulation of the mixed-lymphocyte reaction: an anomaly of increased production and decreased T-cell susceptibility during tumor growth. Denbow CJ; Conroy JM; Elgert KD Cell Immunol; 1984 Mar; 84(1):1-13. PubMed ID: 6230157 [TBL] [Abstract][Full Text] [Related]
23. Tumor growth changes responsiveness to and production of granulocyte-macrophage colony-stimulating factor during recognition of self MHC class II molecules. Walker TM; Burger CJ; Elgert KD Oncol Res; 1992; 4(11-12):455-65. PubMed ID: 1299376 [TBL] [Abstract][Full Text] [Related]
24. Modulation of alloreactivity by Mac-1+, -2+, and -3+ macrophages from normal and tumor-bearing hosts: flow cytofluorometrically separated macrophages. Askew D; Burger CJ; Elgert KD Immunobiology; 1990 Dec; 182(1):1-10. PubMed ID: 2151512 [TBL] [Abstract][Full Text] [Related]
25. Interferon-alpha-2b downregulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade. Harvey WH; Harb OS; Kosak ST; Sheaffer JC; Lowe LR; Heerema NA Leuk Res; 1994 Aug; 18(8):577-85. PubMed ID: 7520517 [TBL] [Abstract][Full Text] [Related]
28. Tumor growth alters macrophage responsiveness to macrophage colony-stimulating factor during reactivity against allogeneic and syngeneic MHC class II molecules. Walker TM; Burger CJ; Elgert KD Immunol Invest; 1993; 22(6-7):463-76. PubMed ID: 8262568 [TBL] [Abstract][Full Text] [Related]
29. Opposing actions of c-ets/PU.1 and c-myb protooncogene products in regulating the macrophage-specific promoters of the human and mouse colony-stimulating factor-1 receptor (c-fms) genes. Reddy MA; Yang BS; Yue X; Barnett CJ; Ross IL; Sweet MJ; Hume DA; Ostrowski MC J Exp Med; 1994 Dec; 180(6):2309-19. PubMed ID: 7964503 [TBL] [Abstract][Full Text] [Related]
30. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis. Morello D; Lavenu A; Babinet C Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531 [TBL] [Abstract][Full Text] [Related]
31. Tumor growth changes the contribution of granulocyte-macrophage colony-stimulating factor during macrophage-mediated suppression of allorecognition. Walker TM; Yurochko AD; Burger CJ; Elgert KD Immunobiology; 1992 Sep; 185(5):427-39. PubMed ID: 1452214 [TBL] [Abstract][Full Text] [Related]
32. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO. Klinken SP; Holmes KL; Morse HC; Thorgeirsson SS Exp Cell Res; 1988 Oct; 178(2):185-98. PubMed ID: 2458948 [TBL] [Abstract][Full Text] [Related]
33. Two-color flow cytometric analysis of the expression of MAC and MHC class II antigens on macrophages during tumor growth. Yurochko AD; Burger CJ; Elgert KD Cytometry; 1990; 11(6):725-35. PubMed ID: 2200657 [TBL] [Abstract][Full Text] [Related]
34. Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7. Orlic D; Anderson S; Biesecker LG; Sorrentino BP; Bodine DM Proc Natl Acad Sci U S A; 1995 May; 92(10):4601-5. PubMed ID: 7538677 [TBL] [Abstract][Full Text] [Related]
35. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation. Liebermann DA; Hoffman B Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003 [TBL] [Abstract][Full Text] [Related]
36. Treatment of murine peritoneal macrophages with bacterial lipopolysaccharide alters expression of c-fos and c-myc oncogenes. Introna M; Hamilton TA; Kaufman RE; Adams DO; Bast RC J Immunol; 1986 Oct; 137(8):2711-5. PubMed ID: 3760571 [TBL] [Abstract][Full Text] [Related]
37. Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma. Husain Z; FitzGerald GB; Wick MM J Invest Dermatol; 1990 Nov; 95(5):571-5. PubMed ID: 2121834 [TBL] [Abstract][Full Text] [Related]
38. A murine macrophage cell line, immortalized by v-raf and v-myc oncogenes, exhibits normal macrophage functions. Blasi E; Radzioch D; Durum SK; Varesio L Eur J Immunol; 1987 Oct; 17(10):1491-8. PubMed ID: 3119352 [TBL] [Abstract][Full Text] [Related]
39. Colony-stimulating factor induction of protooncogene expression in rat alveolar macrophages. Schaberg T; Filderman AE Am J Physiol; 1990 Aug; 259(2 Pt 1):L144-50. PubMed ID: 2116733 [TBL] [Abstract][Full Text] [Related]
40. Shifts in macrophage (M phi) surface phenotypes during tumor growth: association of Mac-2+ and Mac-3+ M phi with immunosuppressive activity. Garner RE; Malick AP; Yurochko AD; Elgert KD Cell Immunol; 1987 Sep; 108(2):255-68. PubMed ID: 2957065 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]